§ PHARMACEUTICALS
USD · PharmaceuticalsBIOA
BIOAGE LABS INC
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
96 increased/new, 39 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| a16z Capital Management, L.L.C. | 3.2M | 4.4% | ±0% |
| Cormorant Asset Management, LP | 2.9M | 2.5% | +42% |
| Sofinnova Investments, Inc. | 2.3M | 1.5% | ±0% |
| BlackRock, Inc. | 2.3M | 0.0% | +48% |
| JANUS HENDERSON GROUP PLC | 2.1M | n/a | +412% |
| Octagon Capital Advisors LP | 1.7M | 3.4% | +9% |
◇ AC INTELLIGENCE
Top institutional owners for BIOA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER8.1% · 0 holders
OTHER58.7% · 94 holders
QUALITY / COMPOUNDER12.2% · 10 holders
PASSIVE / INDEX8.4% · 7 holders
DEALER / BANK4.8% · 18 holders
TACTICAL / MACRO4.3% · 3 holders
ACTIVIST1.7% · 1 holder
SYSTEMATIC / QUANT1.3% · 7 holders
INCOME / DEFENSIVE0.6% · 6 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for BIOA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention BIOA yet.